PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK.\', \'Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.\', \'York Biomedical Research Institute, Hull York Medical School, University of York, York, UK.\', \'Cellular Genetics Institute, Wellcome Sanger Institute, Cambridge, UK.\', \'Innovation Methodology and Application Research Theme, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.\', \'Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK; Institute of Transplantation, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. Electronic address: a.j.fisher@newcastle.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2213-2600(21)00408-210.1016/S2213-2600(21)00408-2
?:hasPublicationType
?:journal
  • The Lancet. Respiratory medicine
is ?:pmid of
?:pmid
?:pmid
  • 34871544
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all